Cannabinoid Encyclopedia

Focused research review

TRPV2 cannabinoid target: what the research says

What evidence connects cannabinoids or endocannabinoids with TRPV2 channel activity, binding, or signaling?

Updated July 2026 15 research sources Mostly early-stage research

The short answer

What is the bottom line?

Research has examined TRPV2 cannabinoid target. This page brings together 6 human-study sources, 3 research reviews, and 4 lab, animal, or mechanism sources. Most of the current evidence is preclinical or focused on biological mechanisms. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about TRPV2 cannabinoid target.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on TRPV2 cannabinoid target covers TRPV2; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about TRPV2 cannabinoid target

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly mechanism-focused

TRPV2

This part of the literature focuses on TRPV2. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

6 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

3 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

4 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

Another 2 of 15 research sources could not be placed cleanly into those three groups from the recorded study details.

What these studies actually looked at

The research on TRPV2 cannabinoid target is not one kind of study. This source set includes 7 animal studies, 3 cell or laboratory studies, and 3 narrative or expert reviews. 3

The recorded populations or models include people or patients (6 sources), animal models (4 sources), and cells or tissue models (1 source). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is tRPV2 channel activity, binding, signaling, or pharmacology (15 sources). Closely related outcome names can still describe different measurements. 5

The TRPV2 cannabinoid target source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

narrative or expert review

Cannabinoid Ligands Targeting TRP Channels.

On this page, this source examines THC activity involving TRPV2. 1

Study type
narrative or expert review
Outcome focus
tRPV2 channel activity, binding, signaling, or pharmacology
Evidence stage
evidence still limited

animal study

Cannabidiol sensitizes TRPV2 channels to activation by 2-APB.

On this page, this source examines CBD activity involving TRPV2. 2

Study type
animal study
Population or model
animal models
Outcome focus
tRPV2 channel activity, binding, signaling, or pharmacology
Evidence stage
mechanism-focused research

narrative or expert review

Cannabinoids in the landscape of cancer.

On this page, this source examines THC activity involving TRPV2. 3

Study type
narrative or expert review
Population or model
cells or tissue models
Outcome focus
tRPV2 channel activity, binding, signaling, or pharmacology
Evidence stage
evidence still limited

narrative or expert review

Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia.

On this page, this source examines Cannabinoids activity involving TRPV2. 4

Study type
narrative or expert review
Outcome focus
tRPV2 channel activity, binding, signaling, or pharmacology
Evidence stage
evidence still limited

animal study

Cannabidiol Enhances Microglial Beta-Amyloid Peptide Phagocytosis and Clearance via Vanilloid Family Type 2 Channel Activation.

On this page, this source examines CBD activity involving TRPV2. 5

Study type
animal study
Population or model
people or patients
Outcome focus
tRPV2 channel activity, binding, signaling, or pharmacology
Evidence stage
mechanism-focused research

Safety and limits

What should readers keep in mind?

Research on TRPV2 cannabinoid target should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What evidence connects cannabinoids or endocannabinoids with TRPV2 channel activity, binding, or signaling?

Relevant research is collected here. Most of the current evidence is preclinical or focused on biological mechanisms. 7

Why is there not always a yes-or-no answer?

The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 8

Where can I read the original studies?

Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Cannabinoid Ligands Targeting TRP Channels. narrative or expert review; evidence still limited PubMed 30697147 DOI 10.3389/fnmol.2018.00487
  2. 2
    Cannabidiol sensitizes TRPV2 channels to activation by 2-APB. animal study; mechanism-focused research PubMed 37199723 DOI 10.7554/elife.86166
  3. 3
    Cannabinoids in the landscape of cancer. narrative or expert review; evidence still limited PubMed 34259916 DOI 10.1007/s00432-021-03710-7
  4. 4
    Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. narrative or expert review; evidence still limited PubMed 19070372 DOI 10.1016/j.tips.2008.10.008
  5. 5
    Cannabidiol Enhances Microglial Beta-Amyloid Peptide Phagocytosis and Clearance via Vanilloid Family Type 2 Channel Activation. animal study; mechanism-focused research PubMed 35628181 DOI 10.3390/ijms23105367
  6. 6
    Cannabidiol sensitizes TRPV2 channels to activation by 2-APB. animal study; mechanism-focused research PubMed 36747846 DOI 10.1101/2023.01.27.525817
  7. 7
    Cannabinoid non-cannabidiol site modulation of TRPV2 structure and function. animal study; mechanism-focused research PubMed 36470868 DOI 10.1038/s41467-022-35163-y
  8. 8
    Molecular mechanism of TRPV2 channel modulation by cannabidiol. animal study; mechanism-focused research PubMed 31566564 DOI 10.7554/elife.48792
  9. 9
    The Protective Effect of CBD in a Model of In Vitro Ischemia May Be Mediated by Agonism on TRPV2 Channel and Microglia Activation. animal study; mechanism-focused research PubMed 36292998 DOI 10.3390/ijms232012144
  10. 10
    Tyrosine phosphorylation and palmitoylation of TRPV2 ion channel tune microglial beta-amyloid peptide phagocytosis. animal study; mechanism-focused research PubMed 39227967 DOI 10.1186/s12974-024-03204-6
  11. 11
    Cannabidiol interactions with voltage-gated sodium channels. evidence still limited PubMed 33089780 DOI 10.7554/elife.58593
  12. 12
    Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids. evidence still limited PubMed 29240420 DOI 10.1021/acs.jnatprod.7b00946
See all 15 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Cannabinoid Ligands Targeting TRP Channels. narrative or expert review; evidence still limited / 1 linked research note PubMed 30697147
  2. Cannabinoids in the landscape of cancer. narrative or expert review; evidence still limited / 1 linked research note PubMed 34259916
  3. Cannabidiol sensitizes TRPV2 channels to activation by 2-APB. animal study; mechanism-focused research / 1 linked research note PubMed 37199723
  4. Tyrosine phosphorylation and palmitoylation of TRPV2 ion channel tune microglial beta-amyloid peptide phagocytosis. animal study; mechanism-focused research / 1 linked research note PubMed 39227967
  5. Cannabinoid non-cannabidiol site modulation of TRPV2 structure and function. animal study; mechanism-focused research / 1 linked research note PubMed 36470868
  6. Molecular mechanism of TRPV2 channel modulation by cannabidiol. animal study; mechanism-focused research / 1 linked research note PubMed 31566564
  7. Cannabidiol interactions with voltage-gated sodium channels. evidence still limited / 1 linked research note PubMed 33089780
  8. Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids. evidence still limited / 1 linked research note PubMed 29240420
  9. Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. narrative or expert review; evidence still limited / 1 linked research note PubMed 19070372
  10. TRPV2, a novel player in the human ovary and human granulosa cells. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 37610352
  11. The Protective Effect of CBD in a Model of In Vitro Ischemia May Be Mediated by Agonism on TRPV2 Channel and Microglia Activation. animal study; mechanism-focused research / 1 linked research note PubMed 36292998
  12. The effects of cannabidiol via TRPV2 channel in chronic myeloid leukemia cells and its combination with imatinib. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 34971020
  13. Cannabidiol sensitizes TRPV2 channels to activation by 2-APB. animal study; mechanism-focused research / 1 linked research note PubMed 36747846
  14. Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 23079154
  15. Cannabidiol Enhances Microglial Beta-Amyloid Peptide Phagocytosis and Clearance via Vanilloid Family Type 2 Channel Activation. animal study; mechanism-focused research / 1 linked research note PubMed 35628181